Crown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug ...
SAN DIEGO, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, …